Compare Abeona Therapeutics Inc (ABEO) vs ARK Next Generation Internet ETF (ARKW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs ARK Next Generation Internet ETF — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while ARK Next Generation Internet ETF trades at $145.74. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | ARKW | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $182.20 |
52-Week Low | $4.17 | $114.45 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
ARKW is trading at $150.00, up 3.32% with strong technical momentum showing bullish moving averages and key indicators like ADX signaling upward trend strength. The stock faces resistance near $151-152 with support at $144-142. Recent news highlights ARK Invest's Cathie Wood sharing investments in Magnificent Seven stocks with Bill Ackman, indicating institutional confidence in growth-oriented technology holdings.
The ETF's exposure to innovative technology companies presents growth potential amid AI and digital transformation trends. Key risks include concentration in volatile tech sectors and market sensitivity to interest rate changes. Current technical strength suggests near-term upside potential if resistance levels are breached.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ARK Next Generation Internet ETF
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →
